Collaborative project: Early and rapid methods of diagnosis and therapy of viral infections (SARSCoV2Dx)) - Teilvorhaben: COVID-19: Diagnostik, Therapiestrategien & Management | Pandemic PACT Tracker

Key facts

Disease
COVID-19
Start & end year
2021
2026
Known Financial Commitments (USD)
$8,268,480
Funder
Federal Ministry of Research, Technology and Space (BMFTR)
Principal Investigator
N/A
Research Location
Germany
Lead Research Institution
Universitätsklinikum Jena
Research Priority Alignment
N/A

Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Diagnostics
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable

Abstract

13 Publications linked via Europe PMC

Last Updated:6 days ago

View all publications at Europe PMC

Slimformer: An NLP-based web server for semantic categorization of gene sets.

Nbeal2 Inactivation Triggers Abl1 Stabilisation and Dysregulated Subcellular Localisation of the Multi-Drug-Resistant Protein MDR1 (ABCB1) in Mast Cells.

Age- and sex-associated differences in immune cell populations.

Raman Spectroscopy Can Identify Acute and Persistent Biochemical Changes in Leukocytes From Patients With COVID-19 and Non-COVID-19-Associated Sepsis.

Leveraging mobility data to analyze persistent SARS-CoV-2 mutations and inform targeted genomic surveillance.

Evaluating the potential of vancomycin-modified magnetic beads as a tool for sample preparation in diagnostic assays.

SARS-CoV-2 and its ORF3a, E and M viroporins activate inflammasome in human macrophages and induce of IL-1α in pulmonary epithelial and endothelial cells.

The Neurobeachin-like 2 protein (NBEAL2) controls the homeostatic level of the ribosomal protein RPS6 in mast cells.

Influenza A virus selectively elevates prostaglandin E₂ formation in pro-resolving macrophages.